We now have blood tests that can predict your risk for Alzheimer’s years before symptoms appear— when there is still time for prevention.
#ptau217HD #nflHD #gfapHD
Alzheimer’s is a slow, initially silent 20- to 40+-year pathophysiological cascade. Waiting for symptoms before evaluating your brain is like waiting for flames to burst through the roof before checking the smoke detector.
This is why high-sensitivity p-Tau 217 testing marks a monumental turning point in preventative and longitudinal follow-up medicine. P-Tau 217 can identify Alzheimer's-related pathology in pre-symptomatic and early symptomatic individuals. When evaluated alongside NfL (a marker of ongoing neuronal damage) and GFAP (a marker of astrocytic neuroinflammation and repair)—as we do in Apollo Health's BrainScan blood test—you get an accurate view of what is happening inside the brain, so just as we should all know our blood pressure and lipid profile, we should also know our p-Tau 217.
Comment ptau217, and I'll send you a link to learn more about p-Tau 217.
